# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA961203 | F | Antiviral activity against HPV-16 infected in human W12-20850 cells after 4 days by non-radioactive hybrid capture technique | Human papillomavirus type 16 | 29 | organism-based format | Scientific Literature | ||
2. | ALA1063960 | F | Antiviral activity against Human papillomavirus 16 infected in human W12-20850 cells by hybrid capture method | Human papillomavirus type 16 | 32 | organism-based format | Scientific Literature | ||
3. | ALA1071243 | F | Antiviral activity against Human papillomavirus - 16 infected in human W12-20850 cells by hybrid capture method | Human papillomavirus type 16 | 33 | organism-based format | Scientific Literature | ||
4. | ALA1697322 | F | Antiviral activity against HPV-16 infected in Caski cells assessed as inhibition of viral replication after 3 days | Human papillomavirus type 16 | 2 | organism-based format | Scientific Literature | ||
5. | ALA1697325 | F | Antiviral activity against HPV-16 infected in Caski cells assessed as inhibition of viral replication after 7 days | Human papillomavirus type 16 | 2 | organism-based format | Scientific Literature | ||
6. | ALA3238559 | F | Antiviral activity against HPV16 assessed as inhibition of viral replication | Human papillomavirus type 16 | 2 | organism-based format | Scientific Literature | ||
7. | ALA3374947 | F | Inhibition of retrograde transport of HPV16 pseudovirus expressing HcRed reporter infected in SVG-A cells assessed as reduction in co-localization of viral capsid protein L1 and golgi protein TGN46 pre-incubated for 0.5 hrs with compound before viral infection for 1 hr followed by incubation with compound at 0.1 mM for 16 hrs by proximity ligation assay | Human papillomavirus type 16 | 1 | organism-based format | Scientific Literature | ||
8. | ALA3370203 | F | Antiviral activity against HPV16 pseudovirus expressing HcRed reporter infected in HeLa-M cells assessed as reduction in viral infectivity pre-incubated for 0.5 hrs with compound before viral infection for 72 hrs by flow cytometry | Human papillomavirus type 16 | 2 | organism-based format | Scientific Literature | ||
9. | ALA3370206 | F | Inhibition of retrograde transport of HPV16 pseudovirus expressing HcRed reporter infected in SVG-A cells assessed as reduction in co-localization of viral capsid protein L1 and golgi protein TGN46 pre-incubated for 0.5 hrs with compound before viral infection for 1 hr followed by incubation with compound at 0.05 mM for 16 hrs by proximity ligation assay | Human papillomavirus type 16 | 1 | organism-based format | Scientific Literature | ||
10. | ALA5215184 | F | Antiviral activity against HPV16 infected in human HEK293T cells assessed as viral growth inhibition incubated for 72 hrs by by green fluorescent protein based method | Human papillomavirus type 16 | 1 | organism-based format | Scientific Literature |